Kripton Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 26.61%
- Profit Growth 18.59%
- Ebitda 243.79%
- Net Worth 10.11%
- Total Assets 4.91%
About Kripton Biotech
Kripton Biotech Private Limited (KBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 May 2006 and has a history of 18 years and nine months. Its registered office is in Meerut, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Goel, Rajnish Goel, and Nidhi Goel serve as directors at the Company.
Company Details
-
Location
Meerut, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231UP2006PTC031810
-
Company No.
031810
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 May 2006
-
Date of AGM
20 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Kripton Biotech Private Limited offer?
Kripton Biotech Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Digestive System Drugs & Medicines, Laxatives, Nutraceuticals & Dietary Supplements, Dietary Supplements, Antacid Drugs, Gastrointestinal Drugs, Common Disease Medicines, Allopathic Cough Syrup.
Who are the key members and board of directors at Kripton Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Goel
|
Director | 11-May-2006 | Current |
|
Rajnish Goel
|
Director | 11-May-2006 | Current |
|
Nidhi Goel
|
Director | 16-Jul-2011 | Current |
Financial Performance of Kripton Biotech.
Kripton Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.61% increase. The company also saw a substantial improvement in profitability, with a 18.59% increase in profit. The company's net worth Soared by an impressive increase of 10.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kripton Biotech?
In 2020, Kripton Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kripton Biotech?
Unlock and access historical data on people associated with Kripton Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kripton Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kripton Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.